Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen type XXVI alpha 1 chain (COL26A1)
- Target
- COL26A1
- Molecular classification
- Collagen family, Structural extracellular matrix protein
01
Overview
Collagen type XXVI alpha 1 chain is a fibrillar collagen component belonging to the collagen superfamily of extracellular matrix (ECM) structural proteins. It is encoded by the COL26A1 gene and forms homotrimers that contribute to tissue structural integrity. Expression studies in mouse development demonstrate localization in somites, mesenchymal tissues of the head, and branchial arches during embryogenesis, suggesting a role in early tissue organization. Unlike many other collagen types, type XXVI has not been directly linked to common connective tissue disorders, nor is it recognized as a therapeutic target for drugs or disease biomarker in current biomedical literature.
- Other names
- Collagen alpha-1(XXVI) chainCOL26A1
02
Biological functions
Extracellular matrix organizationCellular structural supportDevelopmental tissue morphogenesis
03
Disease associations
Other (no direct association with major human diseases such as cancer, inflammation, or neurodegenerative disease found in available databases or literature)
Beyond the preview
Go deeper on Collagen type XXVI alpha 1 chain (COL26A1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Collagen type XXVI alpha 1 chain (COL26A1).